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Introduction
Oral appliance (OA) therapy for obstructive sleep apnea (OSA) attracted attention in the Western countries in the early 1990s. In Japan, OA became an accepted treatment option for OSA in the mid1990s, and was introduced into the National Health Insurance in 2004. OSA is normally diagnosed by doctors. This is because many sleep disorders exist as a differential diagnosis. When doctors select OA as the mode of treatment, they request the dentist to fabricate the device. If the patients report with a referral from a doctor, they are eligible to receive OA therapy through the National Health Insurance.
The dentists who collaborate with specialists in sleep medicine perform OA therapy. These are usually dentists working at general hospitals or dental hospitals. Dental students in Japan also have received sufficient education on OA therapy for OSA. Some textbooks on OA therapy for OSA have been published, and scientific organizations of sleep dental medicine have been inaugurated in many countries including Japan. There will now be more opportunities for clinic-based dentists to handle OA therapy. Hence, we reviewed the currently available evidence on OA therapy and provide the information useful for clinic-based dentists to perform OA therapy. In particular, we have focused on and discussed the importance of follow-up monitoring. Regarding the type of OA, mandibular advancement oral appliance (OAm) has been considered more mainstream. The clinical research evidence used systematic reviews (SR) on OAm for this study.
Review of SRs

Search results
The primary database used was Medline (via PubMed). No limits were applied to the year of study, but only studies published in the English language were included. A thorough literature search was conducted, and was completed on Total 89 Considering the effectiveness in reducing both AHI and ESS, CPAP was ranked the best, followed by OAm and positional therapy, while lifestyle modification alone was the least effective intervention. Chen, 2018 J Oral Maxillofac Surg.
Changes in the upper airway after therapy (computational fluid dynamics analysis) 2 on Am In the responders to OAm therapy, the velocity, wall static pressure, and airway resistance of the upper airway decreased. In nonresponders to OAm therapy, the wall static pressure and airway resistance of the upper airway increased. Araie, 2018 Sleep Med Rev. Side effects of OAm 21 Significant change of OJ, OB, and L1-MP was observed in patients with long-term OA use, while there were no significant changes of skeletal indices or mandibular rotation. Zhang, 2018 Cranio.
Comparison between OAm and CPAP (AHI, lowest SpO2)
14
Even though CPAP can better decrease the severity of OSA, more patients opted for OAm, which showed better results in severe patients, especially adjustable OAm. Martins, 2018 Dental Press J Orthod.
Side effects of OAm 6
The limited available evidence suggests that OAm therapy for snoring and OSA results in changes in craniofacial morphology that are predominantly dental in nature, especially on a long-term basis. Bartolucci, 2019 Eur J Orthod. [2] included studies on OA, but not OAm. Liu et al. [3] did not describe the types of OA, and hence those SRs were excluded. Ultimately, 27 articles were included [1, . Descriptions of the included SRs are shown in Table 1 . In 2016, Al-Jewair et al. [30] examined the methodological quality of the SRs and the meta-analyses (MA) on OA therapy. They concluded that the SRs on OA therapy for adult and pediatric sleep-disordered breathing'were conducted with an overall acceptable methodological quality. Breakdown of the content of the 27 SRs is as follows: there were 10 articles on comparison with other treatments [1, 9, 12, 13, [18] [19] [20] 22, 24, 27] , five articles on the types of OAm [5, 6, 14, 16, 21] , and six articles on the effect of OAm and the associated side effects [4, 8, 23, 26, 28, 29] . There were also three articles on predicting the therapeutic effect of OAm [10, 11, 15] , two articles on changes in the upper respiratory tract caused by this therapy [7, 25] , and one article on a remotely controlled mandibular positioner [17] . The SR by Okuno et al. [15] based on predicting the therapeutic effects of OAm was the latest. They concluded that the predictive accuracy varied depending on the definitions of treatment success used, as well as the type of index test.
Comparison with other treatments
The SRs on comparison of OAm with other treatments always included nasal continuous positive airway pressure (CPAP). OSA symptoms were set as study outcomes, and these included Apnea Hypopnea Index (AHI), Epworth Sleepiness Scale, and Quality of Life. Cross-over studies were also included; and hence, there were a large number of short-term studies. All the SRs stated that the CPAP was more effective than OAm with respect to the aforementioned outcomes. Cammaroto et al. [20] concluded that CPAP still must be considered the gold standard treatment for OSA, and OAm may be included in the list of alternative options. Kuhn et al. [18] examined the Quality of Life index and commented that CPAP was effective in achieving this outcome. They also carefully commented that investigation with a randomized controlled trial (RCT) was needed. Schwartz et al. [22] examined adherence, and analyzed that the usage time of CPAP is around one hour shorter than that of OAm. However, these results demonstrated a high degree of heterogeneity between studies.
CPAP and OAm are the two major conservative treatment options for OSA. We also reached the final conclusion that CPAP is superior to OAm in terms of improving OSA symptoms, as typified by the AHI. There is still room to investigate adherence. It is particularly essential to monitor the adherence of patients who have withdrawn from CPAP therapy, when they use OAm. On the other hand, in clinical practice, it is important to pursue the reason why patients are unable to use CPAP or OAm continuously, and take action to exclude the respective causes. Good adherence can be achieved within a few months.
Types of OAm
There are various types of OAm. OAm are broadly divided into two types: types with upper and lower jaws separated and types with fixed jaws. In Japan, when OA therapy is provided through the National Health Insurance, the fixed types of OAm are often used to balance the costs of the technician. In this review, we searched through five SRs on types of OAm. Ahrens investigated the subjective patient-centered outcomes [5] and polysomnographic indices [6] . They concluded that they were unable to demonstrate the most effective type of OA through both investigations. SerraTorres et al. [14] concluded that adjustable and custom-made OAms give better results than fixed and prefabricated appliances; and monobloc appliances cause more adverse effects. However, this conclusion was their interpretation of the included observational studies. Sivaramakrishnan and Sridharan [21] compared the titratable OAm with the fixed non-titratable OAm. He included five studies. Four of the five studies were observational, and one was a short-term cross-over randomized trial. There was a high degree of heterogeneity between the study results, so they did not conduct a meta-analysis. Therefore, they concluded that "This SR does not demonstrate significant advantages in using titratable appliances". This field has many unresolved questions. It is essential to investigate adherence in addition to improvement of OSA symptoms, typified by the AHI. It is also necessary to investigate the long-term dental and skeletal side effects.
OAm positions the lower jaw anteriorly, thereby improving upper respiratory tract obstruction. Bartolucci et al. [16] investigated the anterior positioning of the lower jaw. They included RCT data to analyze the ratio of the maximum possible distance of anterior movement and improvement rate of AHI, using a bubble plot. They concluded that the improvement in the AHI was not proportional to the increase in mandibular advancement. We also found that the appropriate position of the lower jaw is not uniform, and it differs depending upon the individual. However, in Japan, where the fixed OAm (non-titratable, but adjustable OAm) is mainstream, it is worthwhile to provide dentists with an indication of the initial position of the mandible.
Effect of OAm and side effects
An important outcome of OSA treatment is prevention of complications typified by cardiovascular disease, and reducing the mortality associated with these complications. This outcome is more important for severe cases of OSA. Mild cases also require caution with increase in the baseline of AHI caused by aging and weight gain. There are two SRs on improvement of cardiovascular disease [8, 23] . Iftikhar et al. [8] evaluated blood pressure, and concluded that the pooled estimate shows a favorable effect of OAm on blood pressure. However, he also stated that almost all the data came from observational studies. Five years later, de Vries et al. [23] evaluated the cardiovascular effects. All the RCTs had a follow-up period of three months, which was considered to be too short. De Vries et al. [23] also commented that one study [31] showed that OAm was as effective as CPAP in reducing death from a cardiovascular cause, but that study was not an RCT, and it probably had selection bias. We believe using a propensity score and conducting a long-term observational study with a carefully designed OAm could resolve this question.
The SR by Hoekema et al. [4] was the first one on OAm. They compared OAm with other treatments, conducted a meta-analysis on evaluation of the type of device, and also evaluated side effects. After that, there were no SRs published on side effects for some time. Patients can tolerate many short-term side effects. However, there are irreversible side effects among those that occur over the long-term. There has been an increase in the number of studies with longer study periods. An SR on long-term side effects has recently been published [26, 28, 29] . There were differences in the number of studies included in the three SRs. The reason for this is that Martins et al. [28] included RCTs only. There were differences in the studies included by Araie et al. [26] and Bartolucci et al. [29] because of the search date, and Bartolucci et al. [29] only targeted studies where OAm was used for two or more years. The interpretation of the studies differed among the three SRs. For example, the study by Ringqvist et al. [32] was included as an RCT by Martins et al. [28] , and as a non-randomized study by Araie et al. [26] . However, it was not included at all by Bartolucci et al. [29] . Either way, morphological changes in the teeth and skeleton were seen over the long-term (Araie et al. [26] stated that there were no changes in skeletal indices or mandibular rotation). Bartolucci et al. [29] used a bubble plot, and concluded that OAm therapy produces timerelated dental and skeletal side effects.
Araie et al. [26] , stated the importance of clinicians being aware of the side effects. We also emphasize on the duty of dentists to explain the long-term side effects to patients at their initial visit to the clinic. It is vital to deal with these side effects at an early stage. One of the long-term side effects is posterior open bite. Reports indicate that 70% of the patients are unaware of this symptom [33] . The extent of awareness of masticatory disturbances and cosmetic disturbances caused by dental and skeletal side effects differs depending on the patient. Dentists must respond to these long-term side effects on a case-by-case basis. Regular persistent follow-up monitoring is important. Among the SRs included in this study, none investigated long-term adherence. We confirmed this situation in our hospital and also investigated the situation in the studies included in the SRs. In particular, we investigated the examinations conducted by dentists, namely follow-up monitoring.
Consultation rate for follow-up: at our hospital and in literature
Current situation in our hospital
Here we report the current situation in our hospital (Ichikawa General Hospital, Tokyo Dental College). The dentists in this hospital have been treating patients diagnosed with OSA by the division of otolaryngology of this hospital or another hospital with fixed OAm since 1999. The position of the lower jaw was adjusted referencing subjective symptoms or sleep tests. Follow-up monitoring was started once the patient was free of discomfort, and the effect of the device has been confirmed using sleep tests. The longest duration of follow-up monitoring was set as six months. The medical consultation situation was checked every two months, and we contacted patients who had discontinued consultations by telephone. Patients who had not had a medical consultation for one year or more, despite repeated telephone calls, were considered to have discontinued treatment (dropout case).
We surveyed patients who had received OAm therapy in the one-year period between June 2015 and May 2016 (in-hospital ethics review number: I 16-48). The consultation situation of the patients during this period was checked up to February 2019. There were 46 patients in total. Five patients were unable to continue use due to inability to get used to the device or jaw pain. Two patients discontinued treatment due to relocation, and one patient switched to CPAP. OAm therapy was started in the remaining 38 patients, but eight patients stopped reporting for consultations before the sleep test. Approximately 20% of the patients refused to undergo the test to confirm the effect. One patient was found not to have any effect from the sleep test. Finally, 29 patients had the effect of the treatment confirmed with a sleep test, and follow-up monitoring was started for them. Seven of these patients discontinued consultations. During the approximate three years of follow-up monitoring, one in four patients discontinued consultations. Some patients who discontinued consultations are still using OAm. Hence, this value is the percentage of patients who continued consultation, and not the percentage of those who continued to use OAm.
Consultation rate in the literature
We used the studies included in the SRs that investigated longterm side effects [26, 28, 29] . Doff et al. conducted an RCT comparing OAm with CPAP, and reported the results in multiple articles. We checked the Flow diagram by Doff et al. [34] . Seven of the 51 patients who switched to CPAP partway through the study; hence, 44 patients were treated with OAm. Two patients were lost to follow-up in the first two months, and one patient was lost to follow-up by the end of the study, two years later. This good result achieved in their study demonstrates a bias of the cases participating in the RCT. We examined the prospective observational studies included by Araie et al. [26] and Bartolucci et al. [29] . Fransson et al. [35] reported that 12 out of 77 patients (15.6%) discontinued treatment of their own accord during the two-year observation period. Hou et al. [36] reported that 27 out of 151 patients (17.9%) failed to attend follow-up appointments in the three-year observation period. Martínez-Gomis et al. [37] reported that nine out of 40 patients (22.5%) discontinued treatment of their own accord during the five-year observation period. Sharples et al. [38] summarized an investigative report on clinical effectiveness and cost-effectiveness. This was one of the articles excluded from this review. They introduced a French cohort with a 76% usage rate (not consultation rate) over 2.75 years [39] .
The aforementioned data are from the facilities that conducted the research. We estimate that 20-25% of patients stop coming for consultations (including patients still using the device) when OAm therapy is continued for approximately three years in these facilities.
Conclusions
Summary to date
• CPAP is superior to OA in improving OSA symptoms.
• It is necessary to survey the adherence to OAm therapy of patients who stopped CPAP therapy.
• There is little evidence supporting the theory that OAm therapy prevents cardiovascular disease or improves life prognosis.
• OAm therapy has dental and skeletal side effects with long-term use.
• There is still room to investigate the types of OAm. It is particularly essential to investigate adherence and side effects after starting follow-up monitoring (once the effect of OAm has been confirmed).
• A certain percentage of patients discontinue consultations.
Expectations from clinic-based dentists involved in OAm therapy
The clear results are: superiority of CPAP and dental and skeletal side effects of OAm. The latter is especially important for dentists. Long-term follow-up monitoring by dentists is important to deal with this side effects of OAm and worsening of the OSA baseline. This review has reiterated the importance not only of long-term use of the device by patients, but also the importance of reporting for consultations at a medical institution, and being examined by dentists. However, there are a certain number of patients who hesitate to visit general hospitals or dental hospitals. One of the reasons for this is that a large number of the patients are middle-aged men who work during the day. Clinics are easier to attend than hospitals. We believe that providing OAm therapy in a clinic could improve the continuing consultation rate. OAm requires adjustment when patients are treated with dental prosthetics. From this perspective, there are advantages in the clinic-based dentists treating patients with OAm. The maintenance interval for periodontitis is also the ideal interval for follow-up monitoring of OA therapy. Although the purpose of this review was to provide the current evidence of OAm for clinic-based dentists, this review also proves the benefit of dental clinic-based OAm therapy.
On the other hand, the American Academy of Sleep Medicine and the American Academy of Dental Sleep Medicine created a clinical practice guideline in 2015 [40] . This clinical practice guideline recommends that follow-up monitoring is to be continued appropriately by sleep physicians and qualified dentists. It is important to foster dentists who are able to deal with sleep medicine, which includes conducting medical examinations in collaboration with sleep physicians. Enhancing under-graduate and post-graduate education on sleep medicine, and establishing a specialist system are strategies for fostering the ability of dentists to handle OAm therapy in dental clinics. On the other hand, OAm places a burden on the teeth and the jaws. Searching for an alternative therapy is the duty of dentists. We anticipate that increasing the number of dentists involved in sleep medicine will result in the creation of new ideas for an alternative therapy.
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